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Tayfun O¨zc¸elik2,*Ladies and gentleman,
There are many great geneticists, but few are truly
exceptional in the way that Dr. Uta Francke is. I had the
enormous privilege of entering into the world of human
genetics under her mentorship and the great honor of
working with her. Dr. Francke is a pioneer in the field of
molecular and genomic medicine. Her name is synony-
mous with human and mouse chromosome identifica-
tion and gene mapping, discovery of genes involved in
heritable disorders, and studies of their functions and
disease-causing mechanisms.
Today, we have a comprehensive understanding of
genomic architecture, but this was not so only two decades
ago. In the early 1990s, chromosomal localizations of
approximately 10% of the expressed genes were known.
Of those, Dr. Francke mappedmore than 10% single-hand-
edly, just as in fine-needle embroidery. These genes include
those encoding insulin and its receptors, insulin-like
growth-factor receptors 1 and 2; low-density lipoprotein
and its receptors, a-b-g-globins; epidermal and nerve1This article is based on the address given by the author at the meeting of
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The Amegrowth factors; transforming growth factors a and b;
C-reactive protein; synapsins; serotonin receptors; adren-
ergic receptors; lactate dehydrogenase; thymidine kinase;
a1-antitrypsin; glucocorticoid receptor; the major histo-
compatibility complex; and many more.
Dr. Francke was raised in a small town in Germany. She
obtained her baccalaureate from Aufbaugymnasium Id-
stein and studied medicine at the Universities of Frankfurt,
Marburg, and Munich. After a 2 year internship at Klini-
kum rechts der Isar in Munich, she moved to the United
States in 1969 and completed her residency training in
pediatrics at Children’s Hospital Los Angeles. It was during
her postdoctoral years at the University of California in Los
Angeles and San Diego that she began studying chromo-
somes. Her remarkable ability in pattern recognition and
her phenomenal drive for editing and educating herself
to achieve perfection soon led to her unsurpassed
command of cytogenetics. In the four decades that have
passed since then, her achievements culminated in an
exemplary career and she became an elected member of
the European Molecular Biology Organization, the Insti-
tute of Medicine (National Academies), the American Asso-
ciation for the Advancement of Science, and the American
Academy of Arts and Sciences and was an original member
of Highly Cited Researchers (Institute of Science Index).
Using somatic cell hybrids, she defined conservation of
autosomal gene synteny groups in mice and humans,
established that the order of loci on the X chromosome
is different between mice and humans, and demonstrated
cytogenetic approaches to mouse models of human
genetic diseases. On the clinical front, Dr. Francke was
and continues to be a fabulous clinical geneticist: she
delineated several new syndromes, such as 2p partial
trisomy syndrome, duplication 12p mosaicism, and prox-
imal 4p deletion syndrome.
Dr. Francke moved to Yale University in 1978, and for
the next decade, her laboratory became a mecca for gene-
mapping studies. This was the age of gene hunters as
described in late Arthur Kornberg’s book For the Love of
Enzymes: The Odyssey of a Biochemist. Her group definedmi-
crodeletions associated with chronic granulomatous
disease, adrenal hypoplasia, glycerol kinase deficiency,
and last but not least, Duchenne muscular dystrophy. It
was during that period that I met Dr. Francke when I was
a visitingmedical student giving a presentation of a patientthe American Society of Human Genetics (ASHG) on November 9, 2012,
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with lissencephaly at Yale Genetics Grand Round. She
made a few key comments, and its effect was literally like
the American R&B singer Doris Troy’s song ‘‘Just one
look, that’s all it took.’’ I knew who my mentor was going
to be once I graduated from Istanbul Medical School. This
of course is a direct reflection of Dr. Francke’s contagious
enthusiasm, encouragement and optimistic approach to
well-defined scientific questions, and elegantly formulated
hypotheses. In 1999, when she was the president of the
American Society of Human Genetics and the Annual
Meeting convened in San Francisco like now, the party at
the presidential suite was filled with members of her group
from the 1970s, 1980s, and 1990s, and the air was full of
joy and good memories of the years spent in her lab.
Going back to the 1980s, linkage analysis, like physical
mapping, was moving toward the center stage of human
genetics, and Dr. Francke was laying the foundations of
her research activities for the 1990s and beyond. This
time, as a Howard Hughes Medical Institute investigator
at Stanford University, she pioneered the merging of the
two maps—that of loci of disease phenotypes through
linkage analyses and that of physical localizations of ex-
pressed genes to chromosomes. Those genes with a map
location overlapping a disease locus would then become
a candidate gene for that particular disorder. Using this
strategy and various other positional-cloning andmapping
approaches, her group discovered or collaborated in
the discovery of genes responsible for Prader-Willi, Rett,324 The American Journal of Human Genetics 92, 323–324, March 7Williams-Beuren, Wiskott-Aldrich, and Laron syndromes
and Charcot-Marie-Tooth disease type 1A. Please visit
Stanford University’s recently dedicated ‘‘Discovery
Walk,’’ which stretches the entire length of the Medical
School Campus, and see the promenade that features
significant scientific discoveries made at Stanford and
elsewhere during the past 150 years; all are engraved on
nearly 350 black granite panels lining more than 20
benches. On one of the benches facing the Beckman
Center for Molecular and Genetic Medicine, where
Dr. Francke’s laboratory was located, you will see the
stories of Rett and Prader-Willi syndromes.
As we heard at the presidential address of this meeting,
scientists are citizens of the world. Dr. Francke is indeed
a citizen of the world. She collaborated with many
different groups and also explored the globe by experi-
encing the natural beauties and different cultures of all
the continents.
It is not possible to ask Columbus to discover America.
But it is possible to set the direction to sail. During a life-
long journey in science, Dr. Francke always knew in which
direction to sail. Today, she sails toward the new world of
personal genetic information. For geneticists around the
world, she has always been and will continue to be an
inspiration and a role model as a researcher, educator,
clinician, and leader. It is with great honor, admiration,
and humility that I introduce Dr. Uta Francke as the recip-
ient of the 2012 William Allan Award., 2013
